Lazard Asset Management LLC Beam Therapeutics Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 54,575 shares of BEAM stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,575

Previous 46,916 16.32%

Holding current value

$1.47 Million

Previous $1.1 Million 21.66%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.57 - $33.14 $172,863 - $253,819	7,659 Added 16.32%	54,575 $1.34 Million
Q2 2024 Aug 14, 2024	SELL	$21.22 - $32.66 $173,515 - $267,060	-8,177 Reduced 14.84%	46,916 $1.1 Million
Q1 2024 May 14, 2024	SELL	$23.46 - $45.07 $80,068 - $153,823	-3,413 Reduced 5.83%	55,093 $1.82 Million
Q4 2023 Feb 14, 2024	SELL	$17.69 - $30.76 $40,403 - $70,255	-2,284 Reduced 3.76%	58,506 $1.59 Million
Q3 2023 Nov 14, 2023	SELL	$23.01 - $32.46 $39,117 - $55,182	-1,700 Reduced 2.72%	60,790 $1.46 Million
Q2 2023 Aug 14, 2023	SELL	$29.32 - $35.99 $439 - $539	-15 Reduced 0.02%	62,490 $2 Million
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $24,602 - $39,812	816 Added 1.32%	62,505 $1.91 Million
Q4 2022 Feb 14, 2023	SELL	$36.73 - $51.6 $1.92 Million - $2.69 Million	-52,163 Reduced 45.82%	61,689 $2.41 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $231,577 - $409,204	5,820 Added 5.39%	113,852 $5.42 Million
Q2 2022 Aug 09, 2022	BUY	$29.86 - $62.36 $1.11 Million - $2.32 Million	37,182 Added 52.48%	108,032 $4.18 Million
Q1 2022 May 13, 2022	BUY	$53.73 - $82.16 $952,203 - $1.46 Million	17,722 Added 33.36%	70,850 $4.06 Million
Q4 2021 Feb 09, 2022	BUY	$68.02 - $99.06 $1.86 Million - $2.71 Million	27,322 Added 105.87%	53,128 $4.23 Million
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $102,509 - $162,324	1,215 Added 4.94%	25,806 $2.25 Million
Q2 2021 Aug 12, 2021	BUY	$64.12 - $128.71 $1.55 Million - $3.12 Million	24,210 Added 6354.33%	24,591 $3.17 Million
Q1 2021 May 14, 2021	BUY	$71.28 - $120.75 $27,157 - $46,005	381 New	381 $30,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.89B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Beam Therapeutics Inc. Transaction History